Entrada Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q3 2020 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Entrada Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q3 2020 to Q3 2024.
  • Entrada Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 40.6M shares, a 22.1% increase year-over-year.
  • Entrada Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 33.1M shares, a 5.62% increase from 2022.
  • Entrada Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 31.3M shares, a 399% increase from 2021.
  • Entrada Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 6.27M shares, a 467% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 40.6M +7.35M +22.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 34.2M +1.02M +3.07% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 33.5M +1.12M +3.47% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 33.1M +1.76M +5.62% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 33.3M +1.98M +6.34% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 33.2M +1.89M +6.04% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 32.4M +1.13M +3.61% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 31.3M +25M +399% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 31.3M +29.8M +2022% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 31.3M +30M +2288% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 31.2M +30M +2387% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 6.27M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 1.48M +336K +29.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 1.31M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 1.26M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 1.14M Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.